Literature DB >> 9695407

Homeobox genes in hematopoiesis and leukemogenesis.

T Shimamoto1, K Ohyashiki, K Toyama, K Takeshita.   

Abstract

Homeobox genes have a strikingly conserved 61-amino acid sequence, encoding DNA-binding domain. Some homeobox genes, located in four clusters are designated HOX A through D, while others are known as divergent homeobox genes. Many researchers have demonstrated that hematopoietic cells express many homeobox genes. Induced over- and under-expression of these genes has been used to demonstrate their affect on some aspects of hematopoiesis and leukemogenesis. Recently, knock-out mice of homeobox genes by targeted disruption have also been used to examine their hematological effect. There are examples of the aberrant expression of a homeobox gene causing leukemias in humans. In pre-B acute lymphoblastic leukemia (ALL) with t(1;19) translocation, a fusion protein is created between E2A and a homeobox gene PBX. In T-cell ALL with t(10;14) translocation, the HOX 11 gene is deregulated. In acute myeloid leukemia (AML) with t(7;11) translocation, the HOX A9 gene is rearranged. In this review article, many functions of homeobox genes both at the early stem cell level as well as at the later stages of hematopoietic differentiation, and the leukemogenic effect of altered homeobox genes are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9695407     DOI: 10.1016/s0925-5710(98)00024-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  7 in total

Review 1.  The Hox genes and their roles in oncogenesis.

Authors:  Nilay Shah; Saraswati Sukumar
Journal:  Nat Rev Cancer       Date:  2010-04-01       Impact factor: 60.716

2.  Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation.

Authors:  Bramanandam Manavathi; Dennis Lo; Suresh Bugide; Oindrilla Dey; Suzan Imren; Mitchell J Weiss; R Keith Humphries
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

3.  p21 is a transcriptional target of HOXA10 in differentiating myelomonocytic cells.

Authors:  V C Bromleigh; L P Freedman
Journal:  Genes Dev       Date:  2000-10-15       Impact factor: 11.361

4.  The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.

Authors:  Peixiang Wang; Donald R Branch; Meenakshi Bali; Gilbert A Schultz; Paul E Goss; Tianru Jin
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

5.  Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells.

Authors:  C P McGuckin; N Forraz; R Pettengell; A Thompson
Journal:  Cell Prolif       Date:  2004-08       Impact factor: 6.831

6.  HOX transcription factors are potential targets and markers in malignant mesothelioma.

Authors:  Richard Morgan; Guy Simpson; Sophie Gray; Cheryl Gillett; Zsuzsanna Tabi; James Spicer; Kevin J Harrington; Hardev S Pandha
Journal:  BMC Cancer       Date:  2016-02-11       Impact factor: 4.430

7.  Differential expression of HOX genes upon activation of leukocyte sub-populations.

Authors:  Richard Morgan; Karen Whiting
Journal:  Int J Hematol       Date:  2008-03-05       Impact factor: 2.490

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.